• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

61例黏多糖贮积症患者的耳鼻咽喉科表现

Otorhinolaryngological manifestations in 61 patients with mucopolysaccharidosis.

作者信息

Murgasova Lenka, Jurovcik Michal, Jesina Pavle, Malinova Vera, Bloomfield Marketa, Zeman Jiri, Magner Martin

机构信息

Department of Pediatrics and Adolescent Medicine, General University Hospital and First Faculty of Medicine, Charles University, Prague, Czech Republic; Department of ENT, Motol University Hospital and Second Faculty of Medicine, Charles University, Prague, Czech Republic.

Department of ENT, Motol University Hospital and Second Faculty of Medicine, Charles University, Prague, Czech Republic.

出版信息

Int J Pediatr Otorhinolaryngol. 2020 Aug;135:110137. doi: 10.1016/j.ijporl.2020.110137. Epub 2020 May 27.

DOI:10.1016/j.ijporl.2020.110137
PMID:32502916
Abstract

OBJECTIVES

The mucopolysaccharidoses (MPS) are inherited lysosomal storage disorders with multisystemic and highly variable clinical manifestation. ENT symptoms are common and early signs of MPS. The most common ENT diagnoses are chronic/recurrent rhinosinusitis, acute otitis media, otitis media with effusion, hearing loss and airway obstruction.

METHODS

A single-centre retrospective chart review of 61 patients (36 M/25F) with different MPS subtypes (MPS I (n = 15), MPS II (n = 10), MPS III (n = 17), MPS IV (n = 15) and MPS VI (n = 4)) was conducted. The age of ENT presentation and frequency of ENT symptoms, surgeries and their distribution among MPS subtypes was studied. The relationship between ENT presentation, first ENT surgery and the age of diagnosis was also evaluated.

RESULTS

Median age at the first ENT manifestation was 2.8 years, median age at MPS diagnosis 4.1 years. The great majority of patients (90%) manifested at least one ENT diagnosis; often before the diagnosis of MPS (75%). Chronic/recurrent rhinosinusitis was the most prevalent ENT diagnosis (77%), followed by upper airway obstruction (65%) and hearing loss (53%). Chronic/recurrent rhinosinusitis was the first ENT symptom to appear (median age 2.2 years), followed by otitis media with effusion (3.7 years) and hearing loss (4.5 years). At least one ENT surgery was performed in 57% of patients; in 69% before MPS diagnosis was established. Median age of the first ENT surgery was 4.1 years. ENT symptoms and surgical procedures were earliest present in MPS II.

CONCLUSIONS

Our study documents high and early occurrence of various otolaryngologic symptoms in MPS and thus highlights the role of ENT specialist in prompt diagnosis of these rare diseases and their long-term management.

摘要

目的

黏多糖贮积症(MPS)是遗传性溶酶体贮积病,临床表现具有多系统性且高度可变。耳鼻喉科(ENT)症状常见,是MPS的早期体征。最常见的耳鼻喉科诊断为慢性/复发性鼻窦炎、急性中耳炎、分泌性中耳炎、听力损失和气道阻塞。

方法

对61例不同MPS亚型(MPS I(n = 15)、MPS II(n = 10)、MPS III(n = 17)、MPS IV(n = 15)和MPS VI(n = 4))的患者(36例男性/25例女性)进行单中心回顾性病历审查。研究耳鼻喉科症状出现的年龄、耳鼻喉科症状的频率、手术及其在MPS亚型中的分布。还评估了耳鼻喉科症状、首次耳鼻喉科手术与诊断年龄之间的关系。

结果

首次出现耳鼻喉科症状的中位年龄为2.8岁,MPS诊断的中位年龄为4.1岁。绝大多数患者(90%)至少有一项耳鼻喉科诊断;通常在MPS诊断之前(75%)。慢性/复发性鼻窦炎是最常见的耳鼻喉科诊断(77%),其次是上气道阻塞(65%)和听力损失(53%)。慢性/复发性鼻窦炎是最早出现的耳鼻喉科症状(中位年龄2.2岁),其次是分泌性中耳炎(3.7岁)和听力损失(4.5岁)。57%的患者至少进行了一次耳鼻喉科手术;69%在MPS诊断确立之前进行。首次耳鼻喉科手术的中位年龄为4.1岁。耳鼻喉科症状和手术程序在MPS II中出现最早。

结论

我们的研究记录了MPS中各种耳鼻喉科症状的高发性和早期出现情况,从而突出了耳鼻喉科专家在这些罕见疾病的早期诊断及其长期管理中的作用。

相似文献

1
Otorhinolaryngological manifestations in 61 patients with mucopolysaccharidosis.61例黏多糖贮积症患者的耳鼻咽喉科表现
Int J Pediatr Otorhinolaryngol. 2020 Aug;135:110137. doi: 10.1016/j.ijporl.2020.110137. Epub 2020 May 27.
2
[Hearing loss and airway problems in children with mucopolysaccharidoses].[黏多糖贮积症患儿的听力损失和气道问题]
Acta Otorrinolaringol Esp. 2011 Nov-Dec;62(6):411-7. doi: 10.1016/j.otorri.2011.05.003. Epub 2011 Jul 14.
3
Otorhinolaryngological Management in Taiwanese Patients with Mucopolysaccharidoses.台湾黏多糖贮积症患者的耳鼻喉科管理。
Int J Med Sci. 2021 Jul 25;18(15):3373-3379. doi: 10.7150/ijms.61827. eCollection 2021.
4
A retrospective audit of anesthetic techniques and complications in children with mucopolysaccharidoses.黏多糖贮积症患儿麻醉技术及并发症的回顾性审计
Paediatr Anaesth. 2012 Aug;22(8):737-44. doi: 10.1111/j.1460-9592.2012.03825.x. Epub 2012 Mar 2.
5
Characterization of pulmonary function impairments in patients with mucopolysaccharidoses--changes with age and treatment.黏多糖贮积症患者肺功能损害的特征——随年龄和治疗的变化
Pediatr Pulmonol. 2014 Mar;49(3):277-84. doi: 10.1002/ppul.22774. Epub 2013 Feb 8.
6
[Mucopolysaccharide storage diseases. II. Possibilities and problems in diagnostic typing as seen in patients in a pediatric hospital].[黏多糖贮积病。II. 儿童医院患者诊断分型中的可能性与问题]
Kinderarztl Prax. 1980 Sep;48(9):455-70.
7
The management of otolaryngological problems in the mucopolysaccharidoses: a retrospective review.黏多糖贮积症的耳鼻喉科问题管理:一项回顾性研究。
J Otolaryngol. 1991 Jun;20(3):177-83.
8
Cardiac manifestations of the mucopolysaccharidoses.黏多糖贮积症的心脏表现
Circulation. 1975 Oct;52(4):700-5. doi: 10.1161/01.cir.52.4.700.
9
Mucopolysaccharidosis: Otolaryngologic findings, obstructive sleep apnea and accumulation of glucosaminoglycans in lymphatic tissue of the upper airway.黏多糖贮积症:耳鼻喉科检查结果、阻塞性睡眠呼吸暂停以及上气道淋巴组织中糖胺聚糖的蓄积
Int J Pediatr Otorhinolaryngol. 2014 Jun;78(6):944-9. doi: 10.1016/j.ijporl.2014.03.021. Epub 2014 Mar 27.
10
ENT and mucopolysaccharidoses.耳鼻喉科学与黏多糖贮积症。
Ital J Pediatr. 2018 Nov 16;44(Suppl 2):127. doi: 10.1186/s13052-018-0555-0.

引用本文的文献

1
Safety assessment of laronidase: real-world adverse event analysis based on the FDA adverse event reporting system (FAERS).拉罗尼酶的安全性评估:基于美国食品药品监督管理局不良事件报告系统(FAERS)的真实世界不良事件分析
Front Pharmacol. 2025 Aug 20;16:1623921. doi: 10.3389/fphar.2025.1623921. eCollection 2025.
2
Hearing loss in patients with Morquio A syndrome: A scoping review.莫尔基奥A综合征患者的听力损失:一项范围综述。
Medicine (Baltimore). 2025 Jan 10;104(2):e41128. doi: 10.1097/MD.0000000000041128.
3
The diagnosis and management of mucopolysaccharidosis type II.
黏多糖贮积症 II 型的诊断与治疗。
Ital J Pediatr. 2024 Oct 8;50(1):207. doi: 10.1186/s13052-024-01769-9.
4
[Characterization of otorhinolaryngologic manifestations in children with mucopolysaccharide storage disease typeⅠand type Ⅱ].[Ⅰ型和Ⅱ型黏多糖贮积症患儿耳鼻咽喉表现的特征分析]
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2024 Mar;38(3):221-224;229. doi: 10.13201/j.issn.2096-7993.2024.03.008.
5
Adenotonsillar pathology in mucopolysaccharidoses - lysosomal storage predominates in paracortical CD63+ cells.黏多糖贮积症的咽扁桃体病理学——溶酶体贮积主要见于副皮质区 CD63+细胞。
Virchows Arch. 2024 Jan;484(1):135-140. doi: 10.1007/s00428-023-03662-y. Epub 2023 Oct 3.
6
Endoscopic and Image Analysis of the Airway in Patients with Mucopolysaccharidosis Type IVA.IVA型黏多糖贮积症患者气道的内镜及图像分析
J Pers Med. 2023 Mar 9;13(3):494. doi: 10.3390/jpm13030494.
7
Airway Findings in Patients with Hunter Syndrome Treated with Intravenous Idursulfase.接受静脉注射艾度硫酸酯酶治疗的亨特综合征患者的气道检查结果
J Clin Med. 2023 Jan 6;12(2):480. doi: 10.3390/jcm12020480.
8
Sanfilippo Syndrome: Optimizing Care with a Multidisciplinary Approach.桑菲利波综合征:采用多学科方法优化护理。
J Multidiscip Healthc. 2022 Sep 19;15:2097-2110. doi: 10.2147/JMDH.S362994. eCollection 2022.
9
Hearing Loss in Patients With Morquio Syndrome: Protocol for a Scoping Review.黏多糖贮积症IV型患者的听力损失:一项范围综述的方案
JMIR Res Protoc. 2022 Jun 7;11(6):e32986. doi: 10.2196/32986.
10
Otorhinolaryngological Management in Taiwanese Patients with Mucopolysaccharidoses.台湾黏多糖贮积症患者的耳鼻喉科管理。
Int J Med Sci. 2021 Jul 25;18(15):3373-3379. doi: 10.7150/ijms.61827. eCollection 2021.